Cargando…

Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease

PURPOSE: To evaluate the relationship between maternal left ventricular systolic function, utero-placental circulation, and risk of adverse neonatal outcomes in women with cardiac disease. METHODS: 119 women managed in the pregnancy heart clinic (2019–2021) were identified. Women were classified by...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggleton, Elizabeth J., Bhagra, Catriona J., Patient, Charlotte J., Belham, Mark, Pickett, Janet, Aiken, Catherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110658/
https://www.ncbi.nlm.nih.gov/pubmed/35657407
http://dx.doi.org/10.1007/s00404-022-06635-9
_version_ 1785027307129274368
author Eggleton, Elizabeth J.
Bhagra, Catriona J.
Patient, Charlotte J.
Belham, Mark
Pickett, Janet
Aiken, Catherine E.
author_facet Eggleton, Elizabeth J.
Bhagra, Catriona J.
Patient, Charlotte J.
Belham, Mark
Pickett, Janet
Aiken, Catherine E.
author_sort Eggleton, Elizabeth J.
collection PubMed
description PURPOSE: To evaluate the relationship between maternal left ventricular systolic function, utero-placental circulation, and risk of adverse neonatal outcomes in women with cardiac disease. METHODS: 119 women managed in the pregnancy heart clinic (2019–2021) were identified. Women were classified by their primary cardiac condition. Adverse neonatal outcomes were: low birth weight (< 2500 g), small-for-gestational-age (< 10th birth-weight centile), pre-term delivery (< 37 weeks’ gestation), and fetal demise (> 20 weeks’ gestation). Parameters of left ventricular systolic function (global longitudinal strain, radial strain, ejection fraction, average S’, and cardiac output) were calculated and pulsatility index was recorded from last growth scan. RESULTS: Adverse neonatal outcomes occurred in 28 neonates (24%); most frequently in valvular heart disease (n = 8) and cardiomyopathy (n = 7). Small-for-gestational-age neonates were most common in women with cardiomyopathy (p = 0.016). Early pregnancy average S’ (p = 0.03), late pregnancy average S’ (p = 0.02), and late pregnancy cardiac output (p = 0.008) were significantly lower in women with adverse neonatal outcomes than in those with healthy neonates. There was a significant association between neonatal birth-weight centile and global longitudinal strain (p = 0.04) and cardiac output (p = 0.0002) in late pregnancy. Pulsatility index was highest in women with cardiomyopathy (p = 0.007), and correlated with average S’ (p < 0.0001) and global longitudinal strain (p = 0.03) in late pregnancy. CONCLUSION: Women with cardiac disease may not tolerate cardiovascular adaptations required during pregnancy to support fetal growth. Adverse neonatal outcomes were associated with reduced left ventricular systolic function and higher pulsatility index. The association between impaired systolic function and reduced fetal growth is supported by insufficient utero-placental circulation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00404-022-06635-9.
format Online
Article
Text
id pubmed-10110658
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-101106582023-04-19 Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease Eggleton, Elizabeth J. Bhagra, Catriona J. Patient, Charlotte J. Belham, Mark Pickett, Janet Aiken, Catherine E. Arch Gynecol Obstet Maternal-Fetal Medicine PURPOSE: To evaluate the relationship between maternal left ventricular systolic function, utero-placental circulation, and risk of adverse neonatal outcomes in women with cardiac disease. METHODS: 119 women managed in the pregnancy heart clinic (2019–2021) were identified. Women were classified by their primary cardiac condition. Adverse neonatal outcomes were: low birth weight (< 2500 g), small-for-gestational-age (< 10th birth-weight centile), pre-term delivery (< 37 weeks’ gestation), and fetal demise (> 20 weeks’ gestation). Parameters of left ventricular systolic function (global longitudinal strain, radial strain, ejection fraction, average S’, and cardiac output) were calculated and pulsatility index was recorded from last growth scan. RESULTS: Adverse neonatal outcomes occurred in 28 neonates (24%); most frequently in valvular heart disease (n = 8) and cardiomyopathy (n = 7). Small-for-gestational-age neonates were most common in women with cardiomyopathy (p = 0.016). Early pregnancy average S’ (p = 0.03), late pregnancy average S’ (p = 0.02), and late pregnancy cardiac output (p = 0.008) were significantly lower in women with adverse neonatal outcomes than in those with healthy neonates. There was a significant association between neonatal birth-weight centile and global longitudinal strain (p = 0.04) and cardiac output (p = 0.0002) in late pregnancy. Pulsatility index was highest in women with cardiomyopathy (p = 0.007), and correlated with average S’ (p < 0.0001) and global longitudinal strain (p = 0.03) in late pregnancy. CONCLUSION: Women with cardiac disease may not tolerate cardiovascular adaptations required during pregnancy to support fetal growth. Adverse neonatal outcomes were associated with reduced left ventricular systolic function and higher pulsatility index. The association between impaired systolic function and reduced fetal growth is supported by insufficient utero-placental circulation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00404-022-06635-9. Springer Berlin Heidelberg 2022-06-03 2023 /pmc/articles/PMC10110658/ /pubmed/35657407 http://dx.doi.org/10.1007/s00404-022-06635-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Maternal-Fetal Medicine
Eggleton, Elizabeth J.
Bhagra, Catriona J.
Patient, Charlotte J.
Belham, Mark
Pickett, Janet
Aiken, Catherine E.
Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title_full Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title_fullStr Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title_full_unstemmed Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title_short Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
title_sort maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease
topic Maternal-Fetal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110658/
https://www.ncbi.nlm.nih.gov/pubmed/35657407
http://dx.doi.org/10.1007/s00404-022-06635-9
work_keys_str_mv AT eggletonelizabethj maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease
AT bhagracatrionaj maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease
AT patientcharlottej maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease
AT belhammark maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease
AT pickettjanet maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease
AT aikencatherinee maternalleftventricularfunctionandadverseneonataloutcomesinwomenwithcardiacdisease